US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 34.700
  • +0.730+2.15%
Close Nov 4 16:00 ET
  • 37.000
  • +2.300+6.63%
Post 18:48 ET
1.91BMarket Cap385.56P/E (TTM)

Supernus Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
19.46%177.35M
Operating revenue
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
19.46%177.35M
Cost of revenue
-15.05%17.92M
-30.48%16.31M
-3.95%83.78M
-14.49%19.63M
-24.26%19.6M
3.10%21.09M
30.83%23.46M
16.20%87.22M
35.07%22.95M
43.09%25.88M
Gross profit
31.39%150.41M
-2.28%127.34M
-9.70%523.74M
0.22%144.69M
-11.35%134.28M
-23.48%114.47M
-3.17%130.3M
14.92%580.02M
1.63%144.37M
16.18%151.48M
Operating expense
0.71%132.2M
3.79%131.58M
-4.50%510.34M
11.79%125.7M
-16.99%126.6M
-4.54%131.27M
-3.92%126.78M
25.68%534.4M
-16.61%112.44M
56.11%152.51M
Selling and administrative expenses
-1.01%85.9M
1.07%86.52M
-10.83%336.36M
9.88%81.28M
-26.37%82.7M
-13.63%86.78M
-5.37%85.6M
23.78%377.22M
-27.29%73.97M
55.92%112.31M
-Selling and marketing expense
-1.82%58.8M
4.08%59.57M
-14.42%229.19M
15.18%55.28M
-33.74%56.79M
-18.60%59.89M
-5.43%57.23M
--267.79M
--47.99M
69.03%85.7M
-General and administrative expense
0.79%27.1M
-5.00%26.95M
-2.06%107.18M
0.09%26.01M
-2.61%25.92M
-0.03%26.89M
-5.27%28.37M
--109.43M
--25.98M
24.77%26.61M
Research and development costs
7.40%26.18M
17.53%24.93M
22.86%91.59M
31.35%23.35M
15.86%22.66M
48.79%24.38M
1.79%21.21M
-17.59%74.55M
-15.68%17.77M
-0.51%19.55M
Depreciation amortization depletion
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
243.55%20.64M
-Depreciation and amortization
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
243.55%20.64M
Operating profit
208.44%18.21M
-220.37%-4.25M
-70.62%13.4M
-40.53%18.99M
840.79%7.68M
-238.94%-16.8M
34.08%3.53M
-42.62%45.61M
342.37%31.93M
-103.17%-1.04M
Net non-operating interest income expense
711.52%3.73M
-11.59%3.4M
-45.02%8.04M
146.40%1.99M
62.28%1.75M
2,190.91%460K
-69.89%3.84M
213.73%14.62M
119.92%806K
129.61%1.08M
Non-operating interest income
172.48%3.73M
-36.48%3.4M
-51.81%10.45M
-17.25%1.99M
-37.53%1.75M
-23.38%1.37M
-63.63%5.35M
105.21%21.69M
27.19%2.4M
22.88%2.8M
Non-operating interest expense
--0
--0
-65.84%2.42M
--0
--0
-49.72%910K
-22.50%1.51M
-69.82%7.07M
-73.14%1.59M
-70.90%1.72M
Other net income (expense)
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
-507.50%-486K
Special income (charges)
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
-507.50%-486K
-Less:Restructuring and merger&acquisition
-651.27%-4.36M
33.52%-1.1M
-197.45%-1.52M
91.51%-204K
-193.83%-456K
6.33%790K
-347.67%-1.65M
92.19%-510K
-314.64%-2.4M
507.50%486K
-Less:Impairment of capital assets
----
----
--20.19M
----
----
----
----
--0
----
----
Income before tax
253.57%26.3M
-97.31%243K
-95.44%2.77M
-97.18%990K
2,327.25%9.89M
-251.25%-17.13M
-38.76%9.02M
-16.99%60.74M
1,613.31%35.14M
-101.53%-444K
Income tax
139.19%6.39M
101.50%119K
4,440.63%1.45M
-101.92%-185K
1,279.43%25.87M
-571.12%-16.3M
27.19%-7.93M
-99.84%32K
2,570.33%9.66M
-129.64%-2.19M
Net income
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
Net income continuous Operations
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
Minority interest income
Net income attributable to the parent company
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
-91.89%1.75M
Basic earnings per share
1,900.00%0.36
-99.27%0.0023
-98.23%0.02
-96.30%0.0174
-1,066.67%-0.29
-113.33%-0.02
-35.42%0.31
11.88%1.13
840.00%0.47
-92.68%0.03
Diluted earnings per share
1,900.00%0.36
-99.23%0.0022
-98.08%0.02
-95.95%0.0174
-1,066.67%-0.29
-114.29%-0.02
-32.56%0.29
6.12%1.04
975.00%0.43
-92.50%0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M19.46%177.35M
Operating revenue 24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M19.46%177.35M
Cost of revenue -15.05%17.92M-30.48%16.31M-3.95%83.78M-14.49%19.63M-24.26%19.6M3.10%21.09M30.83%23.46M16.20%87.22M35.07%22.95M43.09%25.88M
Gross profit 31.39%150.41M-2.28%127.34M-9.70%523.74M0.22%144.69M-11.35%134.28M-23.48%114.47M-3.17%130.3M14.92%580.02M1.63%144.37M16.18%151.48M
Operating expense 0.71%132.2M3.79%131.58M-4.50%510.34M11.79%125.7M-16.99%126.6M-4.54%131.27M-3.92%126.78M25.68%534.4M-16.61%112.44M56.11%152.51M
Selling and administrative expenses -1.01%85.9M1.07%86.52M-10.83%336.36M9.88%81.28M-26.37%82.7M-13.63%86.78M-5.37%85.6M23.78%377.22M-27.29%73.97M55.92%112.31M
-Selling and marketing expense -1.82%58.8M4.08%59.57M-14.42%229.19M15.18%55.28M-33.74%56.79M-18.60%59.89M-5.43%57.23M--267.79M--47.99M69.03%85.7M
-General and administrative expense 0.79%27.1M-5.00%26.95M-2.06%107.18M0.09%26.01M-2.61%25.92M-0.03%26.89M-5.27%28.37M--109.43M--25.98M24.77%26.61M
Research and development costs 7.40%26.18M17.53%24.93M22.86%91.59M31.35%23.35M15.86%22.66M48.79%24.38M1.79%21.21M-17.59%74.55M-15.68%17.77M-0.51%19.55M
Depreciation amortization depletion 0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M243.55%20.64M
-Depreciation and amortization 0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M243.55%20.64M
Operating profit 208.44%18.21M-220.37%-4.25M-70.62%13.4M-40.53%18.99M840.79%7.68M-238.94%-16.8M34.08%3.53M-42.62%45.61M342.37%31.93M-103.17%-1.04M
Net non-operating interest income expense 711.52%3.73M-11.59%3.4M-45.02%8.04M146.40%1.99M62.28%1.75M2,190.91%460K-69.89%3.84M213.73%14.62M119.92%806K129.61%1.08M
Non-operating interest income 172.48%3.73M-36.48%3.4M-51.81%10.45M-17.25%1.99M-37.53%1.75M-23.38%1.37M-63.63%5.35M105.21%21.69M27.19%2.4M22.88%2.8M
Non-operating interest expense --0--0-65.84%2.42M--0--0-49.72%910K-22.50%1.51M-69.82%7.07M-73.14%1.59M-70.90%1.72M
Other net income (expense) 651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M-507.50%-486K
Special income (charges) 651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M-507.50%-486K
-Less:Restructuring and merger&acquisition -651.27%-4.36M33.52%-1.1M-197.45%-1.52M91.51%-204K-193.83%-456K6.33%790K-347.67%-1.65M92.19%-510K-314.64%-2.4M507.50%486K
-Less:Impairment of capital assets ----------20.19M------------------0--------
Income before tax 253.57%26.3M-97.31%243K-95.44%2.77M-97.18%990K2,327.25%9.89M-251.25%-17.13M-38.76%9.02M-16.99%60.74M1,613.31%35.14M-101.53%-444K
Income tax 139.19%6.39M101.50%119K4,440.63%1.45M-101.92%-185K1,279.43%25.87M-571.12%-16.3M27.19%-7.93M-99.84%32K2,570.33%9.66M-129.64%-2.19M
Net income 2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M
Net income continuous Operations 2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M
Minority interest income
Net income attributable to the parent company 2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M-91.89%1.75M
Basic earnings per share 1,900.00%0.36-99.27%0.0023-98.23%0.02-96.30%0.0174-1,066.67%-0.29-113.33%-0.02-35.42%0.3111.88%1.13840.00%0.47-92.68%0.03
Diluted earnings per share 1,900.00%0.36-99.23%0.0022-98.08%0.02-95.95%0.0174-1,066.67%-0.29-114.29%-0.02-32.56%0.296.12%1.04975.00%0.43-92.50%0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data